Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
July 21, 2008

Cenix to Discover miRNA Modulators for Regulus in Immunology and Inflammation

  • Cenix BioScience will help Regulus Therapeutics discover novel therapeutic miRNA modulators for use in immunology and inflammation. The company will screen libraries of synthetic miRNA modulators designed and produced by Regulus, using multiparametric assays to identify lead molecules. Cenix will combine high-throughput applications of small RNA-based gene silencing with high-content phenotypic analyses in cultured human cells.